Literature DB >> 1789614

[Balloon dilatation of tracheobronchial stenoses in children. Apropos of 4 cases].

J M Polonovski1, L Hertz Panier, M Francois, C Garel, M Hassan, P Narcy.   

Abstract

Long-lasting tracheal tubing in newborns and infants, associated with repeated tracheobronchial aspiration, is sometimes complicated by tracheal and/or bronchial stenoses. Many therapeutic methods have been described to treat this condition: use of dilatators, laser, surgery, insertion of prosthetic material. Dilatation with an angioplasty balloon has been recently described for the treatment of various stenoses. The authors report about 3 cases of acquired tracheobronchial stenosis which were successfully treated with this method, and 1 case of complex tracheal stenosis (with a double inflammatory and congenital nature) which required both dilatation and surgery. The technique is described. There is no morbidity and no mortality in this non-randomized series. Balloon dilatation is a simple and effective method, which may be proposed as a first-intention treatment for acquired tracheobronchial stenosis in newborns and infants.

Entities:  

Mesh:

Year:  1991        PMID: 1789614

Source DB:  PubMed          Journal:  Ann Otolaryngol Chir Cervicofac        ISSN: 0003-438X


  3 in total

1.  Balloon dilation laryngoplasty for acquired subglottic stenosis at a tertiary center in India.

Authors:  Kalpesh B Patel; Oman Prajapati; Vaidik Mayurkumar Chauhan; Chinmayee Joshi; Dipesh Darji
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-08-18

Review 2.  From electrocautery, balloon dilatation, neodymium-doped:yttrium-aluminum-garnet (Nd:YAG) laser to argon plasma coagulation and cryotherapy.

Authors:  Ashutosh Sachdeva; Edward M Pickering; Hans J Lee
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

3.  Bilateral bronchial balloon dilatation and Strecker stent implantation in a ventilated child with malignant carinal stenosis.

Authors:  T Nicolai; R M Huber; K J Pfeifer; K Schneider; K Mantel; C Schött
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.